Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study

被引:29
|
作者
Costello, Emmet [1 ,2 ]
Rooney, James [3 ,4 ]
Pinto-Grau, Marta [1 ,2 ]
Burke, Tom [1 ,2 ]
Elamin, Marwa [2 ]
Bede, Peter [2 ]
McMackin, Roisin [2 ]
Dukic, Stefan [2 ,5 ]
Vajda, Alice [2 ]
Heverin, Mark [2 ]
Hardiman, Orla [2 ]
Pender, Niall [1 ,2 ]
机构
[1] Beaumont Hosp, Dept Psychol, Dublin 9, Ireland
[2] Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin D02 R590 2, Ireland
[3] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland
[4] Univ Hosp, Inst & Clin Occupat Social & Environm Med, Munich, Germany
[5] Utrecht Brain Ctr, Dept Neurol, Univ Med Ctr, Utrecht, Netherlands
来源
基金
爱尔兰科学基金会;
关键词
EDUCATION;
D O I
10.1136/jnnp-2020-324992
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Amyotrophic lateral sclerosis (ALS) is often associated with cognitive and/or behavioural impairment. Cognitive reserve (CR) may play a protective role in offsetting cognitive impairment. This study examined the relationship between CR and longitudinal change in cognition in an Irish ALS cohort. Methods Longitudinal neuropsychological assessment was carried out on 189 patients over 16 months using the Edinburgh cognitive and behavioural ALS screen (ECAS) and an additional battery of neuropsychological tests. CR was measured by combining education, occupation and physical activity data. Joint longitudinal and time-to-event models were fitted to investigate the associations between CR, performance at baseline and decline over time while controlling for non-random drop-out. Results CR was a significant predictor of baseline neuropsychological performance, with high CR patients performing better than those with medium or low CR. Better cognitive performance in high CR individuals was maintained longitudinally for ECAS, social cognition, executive functioning and confrontational naming. Patients displayed little cognitive decline over the course of the study, despite controlling for non-random drop-out. Conclusions These findings suggest that CR plays a role in the presentation of cognitive impairment at diagnosis but is not protective against cognitive decline. However, further research is needed to examine the interaction between CR and other objective correlates of cognitive impairment in ALS.
引用
收藏
页码:460 / 465
页数:6
相关论文
共 50 条
  • [31] Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
    Nagel, Gabriele
    Uenal, Hatice
    Rosenbohm, Angela
    Ludolph, Albert C.
    Rothenbacher, Dietrich
    BMC NEUROLOGY, 2013, 13
  • [32] Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
    Gabriele Nagel
    Hatice Ünal
    Angela Rosenbohm
    Albert C Ludolph
    Dietrich Rothenbacher
    BMC Neurology, 13
  • [33] The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016-2018: The Ohio Population-Based ALS Registry
    Andrew, Angeline S.
    Pioro, Erik P.
    Li, Meifang
    Shi, Xun
    Gui, Jiang
    Stommel, Elijah W.
    Butt, Tanya H.
    Peipert, Daniel
    Henegan, Patricia
    Tischbein, Maeve
    Cazzolli, Pamela
    Novak, John
    Quick, Adam
    Pugar, K. Doug
    Sawlani, Komal
    Katirji, Bashar
    Hayes, Todd A.
    Horton, D. Kevin
    Mehta, Paul
    Bradley, Walter G.
    NEUROEPIDEMIOLOGY, 2021, 55 (03) : 196 - 205
  • [34] Smoking, Alcohol Consumption and the Risk of Amyotrophic Lateral Sclerosis: A Population-Based Study
    Van den Berg, Leonard
    de Jong, Sonja W.
    Huisman, Marc
    Van der Kooi, Anneke
    De Visser, Marianne
    Schelhaas, Helenius
    Veldink, Jan
    NEUROLOGY, 2011, 76 (09) : A115 - A115
  • [36] Extrapyramidal involvement in amyotrophic lateral sclerosis: results of a prospective population-based study
    Rizzone, M.
    Dematteis, F.
    Chio, A.
    Cammarosano, S.
    Artusi, C.
    Pagani, M.
    Nobili, F.
    Cistaro, A.
    Balma, M.
    Montanaro, E.
    Iazzolino, B.
    Canosa, A.
    Lopiano, L.
    Calvo, A.
    MOVEMENT DISORDERS, 2017, 32
  • [37] Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy
    Zoccolella, S.
    Beghi, E.
    Palagano, G.
    Fraddosio, A.
    Guerra, V.
    Samarelli, V.
    Lepore, V.
    Simone, I. L.
    Lamberti, P.
    Serlenga, L.
    Logroscino, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (03) : 262 - 268
  • [38] Long-term survival in amyotrophic lateral sclerosis: A population-based study
    Pupillo, Elisabetta
    Messina, Paolo
    Logroscino, Giancarlo
    Beghi, Ettore
    ANNALS OF NEUROLOGY, 2014, 75 (02) : 287 - 297
  • [39] Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study
    Ferraro, D.
    Consonni, D.
    Fini, N.
    Fasano, A.
    Del Giovane, C.
    Mandrioli, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (09) : 1426 - 1432
  • [40] Incidence of amyotrophic lateral sclerosis in Europe: A collaborative study of the population-based cohorts
    Logroscino, Giancarlo
    Traynor, Bryan
    Hardiman, Orla
    Chio, Adriano
    Mitchell, Douglas J.
    Swingler, Robert J.
    Millul, Andrea
    Beghi, Ettore
    NEUROLOGY, 2007, 68 (12) : A90 - A91